Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 11698 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 24605 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 24634 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 26467 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 29659 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 30230 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 39766 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 40700 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | 58202 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | Peak area normalized | female | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | Peak area normalized | female | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | Peak area normalized | female | normoglycemic | no neuropathy | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | Peak area normalized | male | pre-diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | 4-HYDROXYPHENYLACETIC ACID (M+H)+ | Peak area normalized | male | pre-diabetic | no neuropathy |